Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2021-09-17 $0.0201 $0.0210 $0.0201 $0.0210 26 322
2021-09-16 $0.0213 $0.0225 $0.0201 $0.0213 3 697
2021-09-15 $0.0250 $0.0250 $0.0200 $0.0200 69 555
2021-09-14 $0.0200 $0.0200 $0.0200 $0.0200 8 153
2021-09-13 $0.0200 $0.0200 $0.0200 $0.0200 662
2021-09-10 $0.0200 $0.0200 $0.0200 $0.0200 94 045
2021-09-09 $0.0200 $0.0203 $0.0200 $0.0203 11 409
2021-09-08 $0.0200 $0.0200 $0.0200 $0.0200 9 940
2021-09-07 $0.0211 $0.0240 $0.0200 $0.0200 11 180
2021-09-03 $0.0211 $0.0279 $0.0211 $0.0240 26 496
2021-09-02 $0.0280 $0.0280 $0.0210 $0.0210 5 572
2021-09-01 $0.0300 $0.0325 $0.0300 $0.0300 30 825
2021-08-31 $0.0280 $0.0360 $0.0280 $0.0300 74 284
2021-08-30 $0.0215 $0.0240 $0.0200 $0.0216 43 952
2021-08-27 $0.0280 $0.0280 $0.0215 $0.0280 14 680
2021-08-26 $0.0270 $0.0280 $0.0231 $0.0280 14 680
2021-08-25 $0.0215 $0.0299 $0.0215 $0.0290 65 455
2021-08-24 $0.0350 $0.0350 $0.0213 $0.0299 313 895
2021-08-23 $0.0298 $0.0350 $0.0220 $0.0330 285 045
2021-08-20 $0.0270 $0.0299 $0.0244 $0.0297 236 007
2021-08-19 $0.0319 $0.0319 $0.0240 $0.0316 185 481
2021-08-18 $0.0278 $0.0358 $0.0240 $0.0290 117 400
2021-08-17 $0.0369 $0.0369 $0.0279 $0.0290 117 400
2021-08-16 $0.0215 $0.0374 $0.0215 $0.0240 59 472
2021-08-13 $0.0310 $0.0310 $0.0240 $0.0240 59 472
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT